Header cover image

Polish (WIG) Biotech Industry Analysis

UpdatedFeb 17, 2025
DataAggregated Company Financials
Companies12
  • 7D-1.5%
  • 3M6.6%
  • 1Y-14.7%
  • YTD5.3%

Over the last 7 days, the Biotech industry has dropped 1.5%, driven by a pullback from Captor Therapeutics Spolka Akcyjna of 9.3%. However, the industry is down 15% over the past year. Looking forward, earnings are forecast to grow by 31% annually.

Industry Valuation and Performance

Has the Polish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Feb 2025zł2.0bzł438.8m-zł94,289,269.0042.2x-21.6x4.6x
Wed, 15 Jan 2025zł1.9bzł406.9m-zł81,163,720.0040.7x-23.3x4.6x
Fri, 13 Dec 2024zł1.9bzł408.7m-zł84,434,269.0038.3x-22.2x4.6x
Sun, 10 Nov 2024zł2.1bzł401.6m-zł85,417,969.0058.8x-24.1x5.1x
Tue, 08 Oct 2024zł2.1bzł438.7m-zł64,845,969.0062.4x-33.1x4.9x
Thu, 05 Sep 2024zł2.2bzł446.6m-zł67,609,784.0065.1x-31.9x4.8x
Sat, 03 Aug 2024zł2.2bzł444.2m-zł64,230,755.0071.5x-33.6x4.9x
Mon, 01 Jul 2024zł2.0bzł444.2m-zł64,230,755.0071x-31.9x4.6x
Wed, 29 May 2024zł2.2bzł439.7m-zł97,717,228.0071x-22.8x5.1x
Fri, 26 Apr 2024zł2.3bzł441.3m-zł93,380,007.0055.5x-24.2x5.1x
Sun, 24 Mar 2024zł2.2bzł462.1m-zł74,341,007.0058.9x-29.1x4.7x
Tue, 20 Feb 2024zł2.3bzł462.1m-zł74,341,007.0060.2x-31.4x5.1x
Thu, 18 Jan 2024zł2.7bzł499.9m-zł66,755,911.0088.6x-40.5x5.4x
Sat, 16 Dec 2023zł2.8bzł499.9m-zł66,755,911.0093.3x-41.6x5.6x
Mon, 13 Nov 2023zł2.6bzł511.7m-zł63,340,678.0046.2x-41.5x5.1x
Wed, 11 Oct 2023zł2.7bzł518.4m-zł60,859,678.0048.7x-43.8x5.1x
Fri, 08 Sep 2023zł2.8bzł521.0m-zł47,585,668.0049.7x-59.9x5.5x
Sun, 06 Aug 2023zł2.8bzł520.7m-zł42,515,291.0051.6x-66.8x5.5x
Tue, 04 Jul 2023zł2.9bzł520.7m-zł42,515,291.0053.4x-67x5.5x
Thu, 01 Jun 2023zł2.9bzł515.9m-zł50,000,721.0062.7x-57.2x5.5x
Sat, 29 Apr 2023zł2.9bzł536.5m-zł32,904,449.0068.2x-89.3x5.5x
Mon, 27 Mar 2023zł2.7bzł488.3m-zł16,018,449.0057.1x-168.4x5.5x
Wed, 22 Feb 2023zł3.0bzł488.6m-zł16,165,349.0067.4x-184.7x6.1x
Fri, 20 Jan 2023zł2.9bzł496.5m-zł10,783,764.0046.9x-271.4x5.9x
Sun, 18 Dec 2022zł2.6bzł496.5m-zł10,783,764.0044.9x-243.4x5.3x
Tue, 15 Nov 2022zł2.7bzł460.6m-zł17,905,868.0047.7x-151.2x5.9x
Thu, 13 Oct 2022zł2.6bzł444.0m-zł13,473,868.0057.4x-190.6x5.8x
Sat, 10 Sep 2022zł2.8bzł401.3m-zł17,023,868.0060.9x-163.2x6.9x
Mon, 08 Aug 2022zł2.8bzł437.0m-zł17,043,314.0036.4x-166.9x6.5x
Wed, 06 Jul 2022zł2.4bzł472.9mzł66,686.0025.2x35595.6x5x
Fri, 03 Jun 2022zł2.5bzł468.2mzł39.0m25x63.8x5.3x
Sun, 01 May 2022zł2.6bzł369.1m-zł37,778,677.0035x-69.4x7.1x
Tue, 29 Mar 2022zł2.7bzł348.8m-zł40,884,677.0032.8x-67.2x7.9x
Thu, 24 Feb 2022zł3.0bzł348.8m-zł40,884,677.0033.4x-73.3x8.6x
Price to Earnings Ratio

-73.3x


Total Market Cap: zł3.0bTotal Earnings: -zł40,884,677.00Total Revenue: zł348.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Polish Biotech Industry Price to Earnings3Y Average 1394.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Polish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.5x is higher than the industry's current PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Polish Healthcare industry?

PL Market2.16%
Healthcare-1.34%
Biotech-1.50%
Biotech-1.50%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PTG Poltregzł39.901.8%
+zł3.3m
-21.5%PS338.3x
BCX Bioceltixzł91.600.4%
+zł2.0m
7.8%PB10.9x
URT Urtestezł90.001.1%
+zł1.4m
-14.3%PB5x
SCS Stem Cells Spinzł0.203.0%
+zł248.0k
-49.0%PS37.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.